Kelly Financial Services’s Myriad Genetics MYGN Stock Holding History

Kelly Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60	Closed	-$1.47K	–	515
2024 Q2	$1.47K	Hold	60	–	–	﹤0.01%	619
2024 Q1	$1.28K	Hold	60	–	–	﹤0.01%	651
2023 Q4	$1.15K	Hold	60	–	–	﹤0.01%	642
2023 Q3	$962	Hold	60	–	–	﹤0.01%	623
2023 Q2	$1.39K	Hold	60	–	–	﹤0.01%	574
2023 Q1	$1.39K	Hold	60	–	–	﹤0.01%	558
2022 Q4	$871	Hold	60	–	–	﹤0.01%	577
2022 Q3	$1.15K	Hold	60	–	–	﹤0.01%	560
2022 Q2	$1.09K	Hold	60	–	–	﹤0.01%	551
2022 Q1	$1.51K	Hold	60	–	–	﹤0.01%	548
2021 Q4	$1.66K	Hold	60	–	–	﹤0.01%	559
2021 Q3	$1.94K	Sell	60 -1,775	-97%	-$58.9K	﹤0.01%	516
2021 Q2	$60K	Buy	1,835 +1,775	+2,958%	+$51.3K	﹤0.01%	435
2021 Q1	$1.83K	Hold	60	–	–	﹤0.01%	509
2020 Q4	$1.19K	Hold	60	–	–	﹤0.01%	503
2020 Q3	$782	Hold	60	–	–	﹤0.01%	503
2020 Q2	$680	Hold	60	–	–	﹤0.01%	522
2020 Q1	$859	Hold	60	–	–	﹤0.01%	477
2019 Q4	$1.63K	Hold	60	–	–	﹤0.01%	432
2019 Q3	$1.72K	Hold	60	–	–	﹤0.01%	413
2019 Q2	$1.67K	Hold	60	–	–	﹤0.01%	391
2019 Q1	$1.99K	Buy	+60	New	+$1.83K	﹤0.01%	372

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Kelly Financial Services's MYGN Position: Q3 2024 in Review

Kelly Financial Services sold out of Myriad Genetics (MYGN) in Q3 2024, closing a stake of 60 shares — an estimated $1.47K sold.

Kelly Financial Services first reported a position in MYGN in Q1 2019 and held it in 22 quarters. The position peaked at $60K in Q2 2021. 246 funds tracked by Wall St. Rank hold MYGN as of Q3 2024.

Kelly Financial Services reported no remaining Myriad Genetics position as of Q3 2024 after selling out during the quarter.
Kelly Financial Services sold 60 Myriad Genetics shares in Q3 2024, an estimated $1.47K.
Kelly Financial Services first reported a position in Myriad Genetics in Q1 2019 and held it in 22 quarters.
Kelly Financial Services's Myriad Genetics position peaked at $60K in Q2 2021.
246 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.